Prestige Consumer Healthcare Inc.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, MCK has a market cap of 89.2B. Regarding current trading prices, PBH is priced at $85.09, while MCK trades at $712.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas MCK's P/E ratio is 27.70. In terms of profitability, PBH's ROE is +0.12%, compared to MCK's ROE of -1.33%. Regarding short-term risk, PBH is less volatile compared to MCK. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, COR has a market cap of 56B. Regarding current trading prices, PBH is priced at $85.09, while COR trades at $288.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas COR's P/E ratio is 33.48. In terms of profitability, PBH's ROE is +0.12%, compared to COR's ROE of +2.41%. Regarding short-term risk, PBH is less volatile compared to COR. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, CAH has a market cap of 36.9B. Regarding current trading prices, PBH is priced at $85.09, while CAH trades at $154.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas CAH's P/E ratio is 24.21. In terms of profitability, PBH's ROE is +0.12%, compared to CAH's ROE of -0.50%. Regarding short-term risk, PBH is more volatile compared to CAH. This indicates potentially higher risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, PBH is priced at $85.09, while ABC trades at $179.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas ABC's P/E ratio is 21.92. In terms of profitability, PBH's ROE is +0.12%, compared to ABC's ROE of +2.52%. Regarding short-term risk, PBH is more volatile compared to ABC. This indicates potentially higher risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, HSIC has a market cap of 8.6B. Regarding current trading prices, PBH is priced at $85.09, while HSIC trades at $70.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas HSIC's P/E ratio is 21.92. In terms of profitability, PBH's ROE is +0.12%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, PBH is less volatile compared to HSIC. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, PBH is priced at $85.09, while PDCO trades at $31.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas PDCO's P/E ratio is 20.48. In terms of profitability, PBH's ROE is +0.12%, compared to PDCO's ROE of +0.14%. Regarding short-term risk, PBH is more volatile compared to PDCO. This indicates potentially higher risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, GRDN has a market cap of 1.3B. Regarding current trading prices, PBH is priced at $85.09, while GRDN trades at $20.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas GRDN's P/E ratio is -12.99. In terms of profitability, PBH's ROE is +0.12%, compared to GRDN's ROE of -0.74%. Regarding short-term risk, PBH is less volatile compared to GRDN. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, OMI has a market cap of 613.7M. Regarding current trading prices, PBH is priced at $85.09, while OMI trades at $8.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas OMI's P/E ratio is -1.68. In terms of profitability, PBH's ROE is +0.12%, compared to OMI's ROE of -0.51%. Regarding short-term risk, PBH is less volatile compared to OMI. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, WGRX has a market cap of 121.4M. Regarding current trading prices, PBH is priced at $85.09, while WGRX trades at $1.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas WGRX's P/E ratio is -2.19. In terms of profitability, PBH's ROE is +0.12%, compared to WGRX's ROE of -1.74%. Regarding short-term risk, PBH is less volatile compared to WGRX. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, ZYXI has a market cap of 65.9M. Regarding current trading prices, PBH is priced at $85.09, while ZYXI trades at $2.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas ZYXI's P/E ratio is -9.08. In terms of profitability, PBH's ROE is +0.12%, compared to ZYXI's ROE of -0.24%. Regarding short-term risk, PBH is less volatile compared to ZYXI. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, GEG has a market cap of 60.9M. Regarding current trading prices, PBH is priced at $85.09, while GEG trades at $2.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas GEG's P/E ratio is -43.60. In terms of profitability, PBH's ROE is +0.12%, compared to GEG's ROE of -0.02%. Regarding short-term risk, PBH is less volatile compared to GEG. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, PBH is priced at $85.09, while HX trades at $2.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas HX's P/E ratio is -1.84. In terms of profitability, PBH's ROE is +0.12%, compared to HX's ROE of -0.04%. Regarding short-term risk, PBH is less volatile compared to HX. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, RDGT has a market cap of 5.6M. Regarding current trading prices, PBH is priced at $85.09, while RDGT trades at $0.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas RDGT's P/E ratio is -0.29. In terms of profitability, PBH's ROE is +0.12%, compared to RDGT's ROE of -0.36%. Regarding short-term risk, PBH is less volatile compared to RDGT. This indicates potentially lower risk in terms of short-term price fluctuations for PBH.

PBH plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PBH stands at 4.2B. In comparison, CVET has a market cap of 0. Regarding current trading prices, PBH is priced at $85.09, while CVET trades at $20.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PBH currently has a P/E ratio of 19.83, whereas CVET's P/E ratio is -69.97. In terms of profitability, PBH's ROE is +0.12%, compared to CVET's ROE of -0.06%. Regarding short-term risk, PBH is more volatile compared to CVET. This indicates potentially higher risk in terms of short-term price fluctuations for PBH.